文献速递泌尿生殖MR

不同厂商前列腺MRI专用协议中ADC测量跨厂商变异的量化研究

Quantification of cross-vendor variation in ADC measurements in vendor-specific prostate MRI-protocols.
PubMed 文献 · Eur J Radiol · 2023-06-21

本研究用双腔圆柱形ADC体模(固定ADC值1,000和1,600×10⁻⁶ mm²/s)在3家厂商6台1.5 T和3 T MRI系统上测试ssEPI、多激发EPI、zoom DWI和TSE DWI序列,参数按PI-RADS v2.1设置。结果显示ADC测量在不同系统和序列间的变异有限,无明显临床相关性,但需前瞻性多中心前列腺癌患者研究进一步验证。

要点

  • 体模ADC与给定ADC的绝对偏差在1.5 T和3 T各序列间有限,作者认为无明显临床相关性。
  • 除3 T下1,600×10⁻⁶ mm²/s腔室的ssEPI和zoom外,各序列ADC测量在不同厂商间均存在显著统计学差异。
  • 部分序列和厂商在1.5 T与3 T之间的ADC测量存在显著差异,但并非全部。

核心结论

  • 本体模研究显示不同MRI系统和前列腺专用DWI序列之间的ADC变异有限,且无明显临床相关性;但作者指出需要前瞻性多中心前列腺癌患者研究进一步调查。

研究设计与样本

  • 体模研究:使用双腔圆柱形ADC体模(固定ADC值1,000和1,600×10⁻⁶ mm²/s),在3家厂商6台MRI系统(1.5 T和3 T)上测试ssEPI、多激发EPI、zoom DWI和TSE DWI四种序列,技术参数按PI-RADS v2.1设置,ADC图由厂商特定算法计算。

诊断标准与关键数值

  • 3 T下与体模给定ADC(约1,000和约1,600×10⁻⁶ mm²/s)的绝对偏差分别为-83至42×10⁻⁶ mm²/s(-8.3%至4.2%)和-48至15×10⁻⁶ mm²/s(-3%至0.9%)。
  • 1.5 T下与体模给定ADC的绝对偏差分别为-81至26×10⁻⁶ mm²/s(-2.6%至8.1%)和-74至67×10⁻⁶ mm²/s(-4.6%至4.2%)。
  • 除3 T下1,600×10⁻⁶ mm²/s腔室的ssEPI和zoom外,所有序列的ADC测量在不同厂商间均存在显著统计学差异。
  • 部分序列和厂商在1.5 T与3 T之间的ADC测量存在显著差异,但并非全部。

临床应用与阅片要点

  • 作者认为本体模研究中ADC在不同MRI系统和前列腺专用DWI序列间的变异有限,无明显临床相关性。
  • 作者指出需要前瞻性多中心前列腺癌患者研究进一步调查。

局限性

  • 作者指出需要前瞻性多中心前列腺癌患者研究进一步调查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose of this study was to quantify the variability of Apparent Diffusion Coefficient (ADC) and test if there were statistically significant differences in ADC between MRI systems and sequences.

METHOD: With a two-chamber cylindrical ADC phantom with fixed ADC values (1,000 and 1,600x10-6 mm2/s) a single-shot (ss) Echo Planar Imaging (EPI), a multi-shot EPI, a reduced field of view DWI (zoom) and a Turbo Spin Echo DWI sequence were tested in six MRI systems from three vendors at 1.5 T and 3 T. Technical parameters were according to Prostate Imaging Reporting and Data System Version 2.1. ADC maps were calculated by vendor specific algorithms. Absolute and relative differences in ADC from the phantom-ADC were calculated and differences between sequences were tested.

RESULTS: At 3 T absolute differences from phantom given ADC (∼1,000 and ∼ 1,600x10-6 mm2/s) were -83 - 42x10-6 mm2/s (-8.3%-4.2%) and -48 - 15x10-6 mm2/s (-3%-0.9%), respectively and at 1.5 T absolute differences were -81 - 26x10-6 mm2/s (-2.6%-8.1%) and -74 - 67x10-6 mm2/s (-4.6%-4.2%), respectively. Significant statistical differences in ADC measurements were identified between vendors in all sequences except for ssEPI and zoom at 3 T in the 1,600x10-6 mm2/s phantom chamber. Significant differences were also identified between ADC measurements at 1.5 T and 3 T in some of the sequences and vendors, but not all.

CONCLUSION: The variation of ADC between different MRI systems and prostate specific DWI sequences is limited in this phantom study and without apparent clinical relevance. However, prospective multicenter studies of prostate cancer patients are needed for further investigation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Møller, Boesen, Hansen, et al. Quantification of cross-vendor variation in ADC measurements in vendor-specific prostate MRI-protocols. Eur J Radiol. 2023. PMID: 37364483. doi:10.1016/j.ejrad.2023.110942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。